USPTO serial 79050568
FRESENIUS
Reviewed by CopyMark Law Group
Reg. 3771611Status 707Registered
- Filing date
- Status date
- Registration date
- Apr 6, 2010
- Examiner
- LEE, JANET H
- Law office
- —
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with FRESENIUS?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Bad Homburg, DE
61352 Bad Homburg, DE
61352 Bad Homburg, DE
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Scott D. Woldow
Scott D. Woldow SMITH, GAMBRELL & RUSSELL, LLP1055 Thomas Jefferson St., NWSuite 400WASHINGTON, DC 20007Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | [ [ Biopharmaceutical preparations for use in the treatment of immunological conditions; Biopharmaceutical preparations for use in the treatment of tissue and organ transplants; Biopharmaceutical preparations for use in the treatment of tumors; Biopharmaceutical preparations for use in the treatment of immune system conditions; medicinal preparations for the treatment of infectious diseases and for use in oncology; Medical fluids for organ perfusion and preservation; Immunosupression agents for use in organ transplantation; trifunctional antibodies for cancer treatment; ] Pharmaceutical and sanitary preparations for dialysis therapy [ ; disinfectants, namely, all purpose disinfectants, disinfectant hand wash and disinfectants for medical instruments; Pharmaceutical preparations, namely, enteral and parenteral nutrition, admixtures to parenteral nutrition, compounding of parenteral nutrition; compound of intravenous drugs, namely, pharmaceutical preparations as a constituent of compound of pharmaceuticals for use in nutritional therapy, immune therapy, paint therapy, cancer therapy, the treatment of infectious diseases, the treatment of blood and blood volume; infusion solutions for the delivery of drugs and pharmaceutical preparations, namely, for parenteral nutrition, for use in nutritional therapy, immune therapy, paint therapy, cancer therapy, the treatment of infectious diseases, the treatment of blood and blood volume, the treatment of oedema and for use in anaesthesia; standard infusion solutions for blood volume replacement and drug reconstitution; pharmaceutical preparations, namely, rinsing solutions for washing purposes, blood volume expanders, antibiotics, anti-infectives, analgesics and anaesthetics; injectable critical care drugs; oral drugs, namely, antibiotics, anti-infectives, analgesics and anaesthetics; pharmaceutical preparations for the treatment of chronic kidney disease; pharmaceutical preparations used in oncology; urology irrigation solutions; sanitary preparations for medical purposes; dietetic substances adapted for medical use, namely, food for medically restricted diets, food for diabetics; food supplements, meal replacement drinks; meal replacement powders; nutritional supplements in paediatrics; disinfectants for sanitary purposes; disinfectants for the skin; medical packaging sets comprising bags, bottles, structural parts and replacement parts filled with pharmaceutical preparations and dietetic products for enteral and parenteral nutrition, admixtures to parenteral nutrition; clinical medical reagents for processing human blood for use in blood transfusions stored in bags; Pharmaceutical solutions used in dialysis; Pharmaceutical preparations for the treatment of blood volume; Intravenous fluids for nutrition and the delivery of pharmaceutical preparations ] ] | SECTION 71 - CANCELLED | — |
| 010 | [ Surgical and medical instruments and apparatus, and medical technical devices, namely, dialysis machines, [ dialysis filters, dialysis monitors, continuous renal therapy hemofiltration and hemodialysis machines, all for dialysis therapy and parts thereof; blood washing machines, surgical clips; medical bags for medical fluids for use in dialysis; ] dialysis pumps [ ; pumps and machines for enteral and parenteral feeding and structural and replacement parts thereof for medical use; medical syringes; needles for medical use; catheters for dialysis; canulae; closure caps for catheters and other parts and fittings in dialysis therapy; tubing for use in dialysis; locks for catheters and other parts and fittings in dialysis therapy; adapters and connectors for use in connection with equipment in dialysis therapy; Surgical and medical instruments and apparatus, namely, enteral feeding tubes, enteral feeding pumps, enteral giving sets for administration of enteral feeding; Programmable infusion medical device, namely, a medical infusion sets for global and interactive management of mono- and multi-channel infusion; infusion medical device, namely, medical machine for capturing and processing infusion data; Patient monitors, namely, a multi-channel patient monitor for critical care for analyzing, programming and monitoring patient information; Patient monitoring sensors and alarms; medical appliances and instruments, namely, syringe pumps and volumetric pumps; Medical apparatus, namely, patient monitoring communication racks for infusion; Surgical and medical apparatus and instruments, namely, infusion sets; Medical apparatus, namely, infusion and injection devices for dialysis and for administering drugs; surgical and medical instruments and apparatus, namely, blood transfusion apparatus; Medical instruments to measure medicine dosage, hydration, nutrition, blood volume, and other physiological and cardiovascular parameters; Medical diagnostic apparatus, analytical apparatus for medical purposes and blood volume measuring apparatus; Medical accessories used in infusion technology, namely, clamps, connectors, syringes, joints for syringes, adapters, bags, cannulas, catheters, needles; Surgical and medical apparatus and instruments, namely, connectors for infusion sets and cannulas and tubes for infusion systems; Surgical and medical apparatus and instruments, namely, implantable subcutaneous catheters with infusion chamber; medical device cannulae for continuous drug application subcutaneous; medical accessories, namely, cannulas for port puncturing and implantable pumps; surgical and medical instruments and apparatus, particularly in connection with the implantation of port systems, namely, introducer instruments; infusion pumps and feeding tubes to administer parenteral drugs and parenteral nutrition solutions including accessories thereto, namely, clamps, connectors, syringes, joints for syringes, adapters, bags, cannulas, catheters and needles; Equipment and disposables used in pharmaceutical compounding of parenteral nutrition and intravenous drugs, namely, medical packaging combinations comprising medical bags and bottles sold empty and parts therefor; safety catheters; Surgical and medical apparatus and instruments, namely, automatic blood and blood component processing machine; surgical and medical apparatus and instruments, namely, blood collection, mixing and weighing machine; surgical and medical apparatus and instruments, namely, blood donation and apheresis couches; surgical and medical apparatus and instruments, namely, docking port for sterile PVC connections and their disposables; surgical and medical instruments and apparatus, namely, seals for medical tubes; surgical and medical instruments and apparatus, namely, tube sealing system comprised of portable medical sealers and a high capacity battery; blood processing equipment for medical use, namely, whole blood cooling, transport and storage containers; haemoglobin screening devices for measuring haemoglobin out of human whole blood and its disposables, namely, cuvettes for single use; blood processing equipment for medical use, namely, automatic blood processing device for platelet concentrates agitation; blood processing disposables, namely, blood bags, pouches, sealers, caps, and containers for collection and processing of whole blood, umbilical cord blood; blood processing disposables for medical use, namely, transfer bags, pouches, sealers, caps and containers for processing and administration of blood components; blood processing disposables for medical use, namely, whole blood and Red cell concentrate in-line filtration for flexible and individual processing; blood processing disposables for medical use, namely, conventional medical filters for leukodepletion and reduction of microaggregates from blood components; blood processing disposables for medical use, namely, cryopreservation device comprising bags, sealers and parts therefor; blood bank accessories for medical use, namely, solutions for the storage and washing of medical devices used in blood procedures; surgical and medical instruments and apparatus, namely, blood cell separator; apheresis device, namely, separation chamber; surgical and medical apparatus and instruments, namely, autotransfusion device; disposables used in autotransfusion, namely, separation chamber; Dialysis machines; Medical device, namely, continuous autotransfusion systems comprised of pumps, centrifuges, washing chambers, blood transfusion bags and tubing for surgical hemotherapy and intensive care and related data management software sold as a unit; Medical instrument, namely, blood transfusion instrument with tubes, clamps, seals and related data management software sold as a unit ] ] | SECTION 71 - CANCELLED | — |
| 041 | Educational services, namely, providing seminars in the fields of nutrition, medical nutrition, extracorporeal blood purification, health, medical treatment and dialysis; providing continuing medical education courses; training services in the field of nutrition, medical nutrition and extracorporeal blood purification; health, medical treatment and dialysis; health education information; nutrition and health education information | ACTIVE | — |
| 044 | Medical services; [ medical services, namely, cell and gene therapy; medical services, namely, vector production gene therapy; ] medical services, namely, dialysis centers for renal therapy [ ; medical services, namely, compounding of pharmaceuticals and medicines ] | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Fresenius SE & Co. KGaA
- Other trademarks owned by Fresenius SE
- Other trademarks owned by Fresenius SE
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 041
- Other trademarks in Class 044
- Similar marks named FRESENIUS
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 19, 2020 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Nov 23, 2020 | INPS | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Nov 23, 2020 | INPC | INVALIDATION PROCESSED | — |
| Nov 16, 2020 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Mar 16, 2020 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Mar 16, 2020 | 71.P | REGISTERED - PARTIAL SEC 71 ACCEPTED | — |
| Mar 11, 2020 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Apr 6, 2019 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Feb 8, 2018 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Apr 7, 2017 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Apr 8, 2016 | INPS | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Apr 8, 2016 | INPC | INVALIDATION PROCESSED | — |
| Feb 10, 2016 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| Jun 10, 2015 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Jun 10, 2015 | 71AG | REGISTERED-SEC.71 ACCEPTED | — |
| Jun 10, 2015 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| May 19, 2015 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Apr 6, 2015 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| May 30, 2013 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 5, 2013 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 23, 2011 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jul 22, 2010 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Jul 22, 2010 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 6, 2010 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 6, 2010 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 19, 2010 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Dec 30, 2009 | NPUB | NOTICE OF PUBLICATION | — |
| Dec 11, 2009 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Dec 10, 2009 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Dec 10, 2009 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Dec 10, 2009 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Dec 10, 2009 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 27, 2009 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 27, 2009 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 25, 2009 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Sep 11, 2009 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Aug 27, 2009 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Aug 27, 2009 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jun 2, 2009 | CNFR | FINAL REFUSAL MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Jun 1, 2009 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 13, 2009 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 13, 2009 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 13, 2009 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 14, 2008 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 13, 2008 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 22, 2008 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 22, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 22, 2008 | ALIE | ASSIGNED TO LIE | — |
| Oct 6, 2008 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Oct 6, 2008 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 25, 2008 | RFNT | REFUSAL PROCESSED BY IB | — |
| Apr 8, 2008 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Apr 8, 2008 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Apr 8, 2008 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Apr 7, 2008 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 2, 2008 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 28, 2008 | NWAP | NEW APPLICATION ENTERED | — |
| Mar 27, 2008 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |